Login

FREE TRIAL  Receive 30 days of no-obligation access. SIGN UP

Home

Top Story

In Social Media Case, Justices Inclined To See Misinfo As Public Health Concern

Supreme Court justices on Monday (March 18) appeared inclined to agree with the Justice Department that, at least some circumstances, government officials should be able to ask social media platforms to remove inaccurate content they think is harming public health, offering hints of their positions during oral arguments in a high-profile case over whether to bar contact between numerous federal health officials and social media platforms.

Change Heathcare News

Wyden Backs Penalties For Providers That Lack Cybersecurity

Senate Finance Committee Chair Ron Wyden (D-OR) is backing HHS’ plan to slap penalties on hospitals and providers starting in fiscal 2029 that do not have cybersecurity procedures in place as a step to prevent future large-scale cyberattacks -- like the Change Healthcare attack -- from crippling the health care system.

OCR Probes UHG For HIPAA Compliance, But Reminds Others To Follow Rules

AHIP Balks As HHS Urges Plans To Pause Prior Auth Due To Change Attack

AHA Seeks Legislative Help With Change Attack Fallout

Latest News

Negotiations between House and Senate leadership on another skinny health package that included pharmacy benefit manager reforms, community health center funding, pandemic response funding and opioid provisions collapsed over the weekend, lowering the chances that health measures will be added to one of the remaining spending bills by the March 22 government funding deadline, according to a senior staffer familiar with the discussions.

President Joe Biden signed an executive order Monday (March 18) aimed at broadening research on women’s health, with key health agencies such as the National Institutes of Health, FDA and CMS directed to ramp up research on menopause, develop new guidance for the inclusion of women in clinical trials and ensure treatments covered by Medicare collect solid evidence of efficacy in women.

AstraZeneca will join Boehringer Ingelheim in capping out-of-pocket costs for its inhaler products at $35 per month, the company announced Monday (March 18).